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Abstract 
Background: Limb remote ischemic postconditioning (LRIP) can ameliorate cerebral ischemia–reperfusion injury 
(IRI), while the underlying mechanism remains elusive. Hypoxia-inducible factor 1α (HIF-1α) is an important transcrip-
tion factor during cerebral ischemia damage. However, whether the neuroprotective effect of LRIP could be associ-
ated with HIF-1α is somewhat unclear. Here we tested the hypothesis that Limb remote ischemic postconditioning 
(LRIP) protecting brain from injury in middle cerebral artery occlusion (MCAO) rat model was associated with HIF-1α 
expression.
Results: LRIP was conducted with 3 cycles of 10 min occlusion/10 min reperfusion at the beginning of reperfusion. 
The analysis of neurobehavioral function and triphenyltetrazolium chloride (TTC) staining showed the neurological 
deficit, brain infarct and cerebral edema, caused by ischemia–reperfusion injury (IRI), were dramatically ameliorated 
in LRIP administrated animals. Meanwhile, the result of Q-PCR and western blot revealed that the overexpression of 
HIF-1α induced by IRI could be notably suppressed by LRIP treatment.
Conclusions: LRIP exhibits a protective effect against cerebral ischemia/reperfusion and the possible mechanism is 
associated with the suppression of HIF-1α in stroke rats.
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Background
Cerebral ischemia, the most common acute cerebrovas-
cular disease, has been recognized as the third leading 
cause of mortality and disability in the worldwide. Up to 
date, few effective therapies could be used for the treat-
ment of cerebral ischemia. Therefore, it is necessary to 
develop new methods for the treatment of brain ischemia 
and the involved mechanism should be investigated.
LRIP is designated as an emerging and developed post-
conditioning procedure, induced by repeated occlusion/
reperfusion cycles in the bilateral femoral arteries. Pre-
vious studies have demonstrated that LRIP could effec-
tively improve outcome in ischemic animal models [1–3], 
therefore possessing potential neuroprotection in allevi-
ating brain edema, reducing cerebral infarct volume and 
blood–brain barrier disruption [4–6]. As a result, LRIP 
could be considered as an effective therapy for brain 
ischemia in future clinic practice. However, the potential 
protective mechanisms of LRIP are waiting to be clari-
fied. HIF-1α, a primary component of the cellular and 
systemic response to hypoxia in mammals, consists of an 
oxygen-regulated α-subunit and a constitutive β-subunit 
[7]. As a master transcriptional regulator of numerous 
genes under hypoxic conditions, HIF-1α not only partici-
pates in regulating angiogenesis, glucose metabolism and 
cell survival during hypoxia [8–10], but also plays a cru-
cial role in the development of apoptosis, inflammation 
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activity [11–14]. Although HIF-1α has been widely 
known to be upregulated in rats subjected to cerebral 
ischemia, but the exact role of HIF-1α is still being 
debated. Moreover, no evidence is to address the role of 
HIF-1α in brain ischemia rats subjected to LRIP. In this 
study, we examined the neuroprotective effect of LRIP 
using MCAO rat model, indicated by neurological defi-
cit score, infarct volume and brain edema. Then, using 
the analysis of Q-PCR, western blot and immunohisto-
chemistry, we detected whether HIF-1α was involved in 
ischemic brain subjected to LRIP.
Methods
Animals and grouping
All SPF grade Sprague–Dawley rats weighing 250–280 g, 
were purchased from animal center of Sichuan University 
and the experimental protocol was approved by the Insti-
tutional Animal Care and Use Committee at Chengdu 
Medical College. At room temperature (22–25  °C), all 
rats were housed in a plastic cages (2 rats per cage) with 
12-h light/dark cycle and had free access to food and 
water. All rats were randomly divided into three groups: 
sham, I/R and LRIP groups. The rats in sham group were 
subjected to surgical operation without occlusion of the 
right middle cerebral artery and LRIP treatment. The rats 
in I/R group were only suffered MCAO injury without 
LRIP treatment. The rats in LRIP group were subjected 
to MCAO group with LRIP treatment. Based on the rep-
erfusion time, I/R and LRIP groups were respectively 
divided into following subgroups, including reperfusion 
1, 3 and 7 days groups.
Focal cerebral ischemia/reperfusion
Transient MCAO, as previously described [15], was used 
to induce focal cerebral ischemia. Rats were anesthetized 
deeply by injection of 3.6 % chloral hydrate (1 ml/100 g, 
IP). Heating lamps were used to maintain temperature at 
36–37.5  °C. To perform brain ischemia, a midline neck 
incision in the neck was prepared. Then, the right com-
mon carotid artery (CCA), internal carotid artery (ICA) 
and external carotid artery (ECA) were exposed and iso-
lated surgically. After the CCA was ligated close to its 
origin with a 3-0 silk suture, a type of 4.0 monofilament 
nylon suture with a slightly enlarged and rounded tip 
(Doccol Cooperation, Redlands, CA, USA) was inserted 
into the ICA,and advanced 18–20 mm until mild resist-
ance, which indicated the middle cerebral artery (MCA) 
was effectively occluded. After 60  min of MCAO, the 
monofilament nylon suture was removed and MCA 
perfusion was restored. The sham group underwent 
the same procedure, but without occlusion of the right 
MCA. In limb remote ischemic postconditioning (LRIP) 
group, LRIP was conducted at the beginning of MCAO 
reperfusion. Briefly, the proximal hind limbs of each rat 
were tightened with rubber bands for 10 min as tight as 
possible, and then the rubber bands were loosened for 
10  min. This process was repeated 3 cycles. The blood 
flow was completely interdicted and was confirmed 
by hypothermia, cyanosis and expansion in the hind 
limbs. When the procedures were finished, the animals 
returned to their cages and again allowed free access to 
food and water.
Assessment of neurological function
The neurological deficit score (NDS) was performed with 
double-blind fashion at 24 h after IRI injury. To assure the 
brain damage in a similar degree as much as possible, the 
1–2 scores animals according to the methods of Longa 
scoring [16] were included in the following experimental 
procedure. The method of Longa scoring is listed as fol-
lows: 0, no deficit; 1, failure to extend left forepaw fully; 
2, circling to the left; 3, falling to the left; and 4, no spon-
taneous walking with a depressed level of consciousness.
The final neurobehavioral scoring in this study was per-
formed according to Garcia JH [15], which contains six 
aspects: spontaneous activity (in case for 5 min); symmetry 
of movements (four limbs); symmetry of forelimbs (out-
stretching while held by tail); climbing wall of wire cage; 
reaction to touch on either side of trunk; response to vibris-
sae touch. Each aspects contain 0–3 points. The total scores 
range 3 from 18. The severity worsens as scores decreased.
Measurement of infarct volumes and cerebral edema
The infarct volume was measured by triphenyltetrazo-
lium chloride (TTC; Sigma) staining as described previ-
ously [17]. Three days after reperfusion, the brains were 
removed and cut into 4-mm-thick coronal sections, 
then the slices were incubated in 0.2 % solution of TTC 
diluted in 0.1 M sodium phosphate buffered saline (PBS) 
(pH 7.4) at 37 °C for 30 min and immersed overnight in 
10  % formalin. The white color represented infarct tis-
sue and red was normal tissue. The sections were pho-
tographed using a digital camera (Olympus, Japan). The 
infarct zone was demarcated and analyzed with Image J 
software (IPP, version 6.0). The ratio of infarct to normal 
volume was calculated as follows: [(area of the cortex in 
the non-ischemic hemisphere—area of the normal cortex 
in the ischemic hemisphere)/area of the non-ischemic 
cortex]  ×  100  % [2, 18]. Cerebral edema was counted 
from sections stained by TTC according to the formula: 
[(ipsilateral volume − contralateral volume)/contralateral 
volume] × 100 % [19].
Quantitative RT‑PCR analysis
According to the manufacturer’s instructions, the 
total RNA of infarcted area was isolated by Trizol 
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reagent (Invitrogen, USA), and then was transcripted 
to cDNA reversedly with the RevertAidTM First Strand 
cDNA Synthesis kit (TaKaRa Biotechnology, Dalian, 
China). Quantitative RT-PCR analysis for the level of 
HIF-1α mRNA was performed by using Prime Script 
RT-PCR kits (Takara) as described. The mRNA level 
of β-actin was as an internal control. The sequences 
of primers used were shown as following: (forward) 
5′-ACCCTCTGATTTAGCATGTAG-3′ and (reverse) 
5′-GTAGGTTTCTGCTGCCTTGT-3′) for HIF-1α; (for-
ward) 5′-GAAGATCAAGATCATTGCTCCT-3′ and 
(reverse) 5′-TACTCCTGCTTGCTGATCCA-3′) for 
β-actin. The real-time PCR program steps were 95 °C for 
1 min, 45 cycles of 95 °C for 5 s, 60 °C for 5 s, and 72 °C 
for 20 s.
Western blot
Brain tissues from infarct cortex were lysed and homog-
enized in RIPA lysis buffer (Beyotime, Jiangsu, China) 
supplied with 2 % of cocktail pill (Roche). Then suspen-
sion was centrifuged at 12,000 r/min for 10  min. And 
protein concentration was qualified with the BCA assay 
kit (Beyotime). 80 ug total protein was separated in 15 % 
SDS–polyacrylamide gel (SDS-PAGE) at 80 V for 2 h and 
transferred to PVDF membranes at 350 mA for another 
2 h as well as was blocked with 5 % nonfat milk dissolved 
by TBST for 1 h at room temperature. Then, the blocked 
membranes were incubated overnight at 4  °C with the 
primary antibody of HIF-1α (rabbit, Abcam, 1:1000). 
After incubated with the primary antibody, the mem-
branes were rinsed with TBST and incubated with the 
secondary antibody for 2 h (goat anti-rabbit IgG, ZSGB-
BIO, China, 1:5000). Finally, ECL was added to mem-
branes to develop image, which was conducted in Alpha 
Innotech (Bio-Rad).
Immunohistochemistry and immunofluorescence
For immunohistochemistry, brains tissues from each 
group were harvested, post-fixed with 4  % paraformal-
dehyde and embedded in paraffin. Then, coronal sec-
tions  (10 µm) were achieved at the level of the anterior 
commissure. When paraffin was removed, sections 
were incubated in 0.3 % H2O2 for 10 min. Then the sec-
tions were disposed with high pressure antigen retrieval 
for 2 min and blocked with 5 % goat serum at 37 °C for 
20 min. Subsequently, they were incubated in the mixture 
of anti-HIF-1α antibody (rabbit, Abcam, 1:50) overnight 
at 4  °C. After washing in PBS, the sections were incu-
bated with corresponding secondary antibody at 37  °C 
for 40  min. Finally, the antibody was visualized using 
DAB staining, then counterstained with hematoxylin, 
dehydrated, mounted, observed with a light microscope 
(Olympus/BX51, Tokyo, Japan) at  400× magnification. 
To compare the positive cell number, six fields from per 
section were captured and analyzed.
For immunofluorescence, sections were pretreated 
with previously, then incubated in the mixture of anti- 
HIF-1α antibody/anti-GFAP(mouse, 1:200, Protein-
tech), anti-HIF-1α antibody (rabbit, Abcam, 1:50)/
anti-NeuN (mouse, 1:200, Abcam), After washed with 
PBS, they were incubated with fluorescence secondary 
antibody IgG (anti-mouse Alexa Fluor 488-conjugated, 
green, 1:100, Proteintech)/IgG (anti-rabbit Alexa Fluor 
594-conjugated, red, 1:100, Proteintech) for 2 h at 37 °C. 
Then, the sections were rinsed with PBS and mounted by 
DAPI. Finally, the pictures were captured by fluorescence 
microscope (Olympus/BX51, Tokyo, Japan) at  400× 
magnification.
Statistical analysis
All data expressed as the mean ±  standard error of the 
mean (S.E.M.). Differences in quantitative data obtained 
from cerebral infarct area, brain edema, NDS, integrated 
densities of protein bands and immunohistochemical, the 
expression of genes were evaluated by one-way analysis 
of variance (ANOVA) and Student’s t test, p < 0.05 was 
considered as statistical significance. Statistical analysis 
was performed with SPSS version 17.0 software (SPSS 
Corp, USA).
Results
Effect of LRIP improving neurological function
As shown in Fig.  1 (each group: n  =  8), Garcia scores 
at different time in sham group were about 18, which 
indicated that there was no neurological deficit. Com-
paratively, after undergoing cerebral ischemia, the rats 
presented severity neurological deficit. At each time 
point of reperfusion, the Garcia scores in I/R group were 
lower than sham group (p < 0.05, Fig. 1). Moreover, the 
scores were notably increased compared with I/R group 
but it was still lower than sham group, when treated with 
LRIP (p  <  0.05, Fig.  1). These confirmed that cerebral 
ischemia injury had resulted in neurological dysfunction, 
while LRIP treatment could inhibit this injured progress. 
These findings showed that the postconditioning treat-
ment could improve the neurological function caused by 
MCAO injury.
LRIP reduced cerebral infarct volume and suppressed 
cerebral edema
To investigate whether LRIP could reduce infarct vol-
ume and cerebral edema in ischemic brain, we measured 
infarct volume and brain edema with TTC staining at 3d 
reperfusion (Fig. 2a). White zone in brain tissues repre-
sented damaged brain areas resulted from ischemia, and 
red zone represented normal brain tissues. Rats in sham 
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group had no ischemic damage, showing red staining 
(Fig. 2a). I/R group exhibited that cerebral infarct volume 
was about 32.20 ±  2.16  %, whereas the LRIP decreased 
the white zone to 21.87 ± 1.98 % (p < 0.05; n = 5; Fig. 2b).
Therefore, brain edema (%) was significantly reduced 
in LRIP group compared with I/R group. These result 
confirmed that LRIP treatment significantly decreased 
infarct volume and brain edema during cerebral ischemia 
injury.
The activation and localization of HIF‑1α
In this study, we tested the activation and distribution of 
HIF-1α in cerebral cortex by using immunohistochemis-
try. As shown in Fig.  3, immunofluorescence confirmed 
that HIF-1α was mainly located in cytoplasm of neurons, 
but few in astrocytes, while ischemia injury could induce 
HIF-1α increase. In sham group, we showed that HIF-1α 
exhibited a basic expression in cortex of brain. After 
ischemia–reperfusion, the number of HIF-1α positive 
neurons was significantly increased at each time point 
(p  <  0.05; Fig.  4). Moreover, LRIP treatment decreased 
effectively the number of HIF-1α positive neurons and 
exhibited statistic significance at 1 and 3 days (p < 0.01; 
Fig.  4). These showed that ischemic postcondition-
ing could suppress the expression of HIF-1α in neurons 
under ischemia condition.
Expression of HIF‑1α mRNA
We determined the mRNA level of HIF-1α in the injured 
brain tissues at day 1, 3 and 7. Q-PCR showed that the 
expression of HIF-1α had a significant rising after 
ischemia and hypoxia (Fig. 5a). At day 1, the mRNA level 
of HIF-1α in I/R group was higher than seen in sham 
group (p < 0.05, Fig. 5a). However, LRIP treatment could 
partly reverse this alteration that mRNA expression 
of HIF-1α in LRIP group was significantly decreased at 
1 day compared with in I/R group (p < 0.05). At 3 days 
and 7 days post operation, the expression of HIF-1α was 
gradually reduced in I/R group compared with sham 
group (p  <  0.05), but there was no statistical change 
between I/R group and LRIP group (p  >  0.05, Fig.  5a; 
n = 5).
Level of HIF‑1α protein
The protein expression of HIF-1α at 3  days was meas-
ured by western blot. As shown in Fig.  5b, the den-
sity of protein bands in sham, I/R and LRIP group was 
0.51 ± 0.07, 1.13 ± 0.11, 0.82 ± 0.09, respectively. Com-
pared with sham group, the expression of HIF-1α in I/R 
was increased significantly (p < 0.05, n = 5). However, in 
LRIP treated animals, the protein expression of HIF-1α 
was notably decreased (p  <  0.05, n  =  5). The result 
demonstrated that LRIP treatment could suppress the 
Fig. 1 The analysis of Garcia JH scores. Quantitative evaluation of 
Garcia scores in different groups at day 1, 3 and 7. Compared with in 
sham group, the Garcia scores were obviously lower in I/R and LRIP 
group at day 1, 3 and 7 (#p < 0.05). Whereas, the LRIP administration 
could ameliorate the neurological function, indicated by increase 
of scores in LRIP group more than I/R group (*p < 0.05). The data is 
presented as mean ± SEM from eight animals per group
Fig. 2 Measurement of infarct volume and edema formation at 3 
days reperfusion after MCAO injury. a At 3 days after ischemia/rep-
erfusion injury, TTC staining showed the brain infarct in I/R and LRIP 
group exhibited white color. b Quantitative evaluation of infarct vol-
umes (%) in different groups was conducted at 3 days after ischemia/
reperfusion injury. Compared with I/R group, the infarct volume 
was markedly diminished in LRIP administration group (*p < 0.05). 
c The brain edema (%) at 3 days was significantly reduced in LRIP 
administration group compared with I/R group. The data is presented 
as mean ± SEM from eight animals per group
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expression of HIF-1α increased by ischemia–reperfusion 
injury.
Discussion
In this study, we found LRIP had the neuroprotective 
effect in brain ischemia rats, and the possible molecular 
mechanism is involving in the change of HIF-1α. Cur-
rently, focal ischemia induced by MCAO, which has 
been widely applied to research the effects and mecha-
nisms of pre- and postconditioning on focal cerebral 
ischemia in the experiment animals. As a newly devel-
oped postconditioning procedure, LRIP was conducted 
immediately after focal cerebral ischemia–reperfu-
sion establishment with three cycles of 10  min banding 
or loosing. As a result, an efficacious neuroprotection 
against brain ischemic injury was observed indicated by 
Garcia JH scores in LRIP administrated rats. TTC stain-
ing revealed that LRIP significantly reduced the cerebral 
infarct volume and relieved brain edema, which showed 
that LRIP could decrease cell death in ischemic area. Our 
Fig. 3 Immunohistochemical staining for HIF-1α in ischemic cerebral cortex at 3d reperfusion after MCAO injury. a Immunofluorescence double 
staining for HIF-1α/NeuN in neurons treated by LRIP. b Immunofluorescence double staining for HIF-1α/GFAP in astrocytes treated by LRIP. The 
immunofluorescence showed nucleus were stained by DAPI with blue color and HIF-1α were stained with green color, neurons were stained by 
NeuN and astrocytes were stained by GFAP with red color, and the co-expression of NeuN with HIF-1α within the same cell showed blue color 
(merged), the co-expression of GFAP with HFI-1α within the same cell showed white color (merged). The arrow showed double staining for HIF-1α/
NeuN or HIF-1α/GFAP (scale bar = 20 μm). c HIF-1α immunoreactivity was marked with brown color in cytoplasm (scale bar = 20 μm)
Fig. 4 Quantitative analysis of HIF-1α positive cells. The analysis of 
HIF-1α positive cells in cerebral cortex. Compared to sham group, 
the number of HIF-1α presented a substantial increase in I/R and 
LRIP group (##p < 0.01) at 3 and 7 days. Compared to I/R group, the 
positive cells were downregulated in LRIP group at 1 and 3 days 
(**p < 0.01)
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observation added the fruitful evidence that was sup-
ported by previous reports [4, 20].
Possible mechanisms underlying the protective effect 
of LRIP may include amelioration of endothelial func-
tion, guarding the integrity of the blood brain barrier, 
modulation protein synthesis and nerve activity [2, 21], 
inhibition of apoptosis [22] and a decrease of reactive 
oxygen species (ROS) [5]. Recently, accumulating experi-
ments focused on inflammatory interactions following 
brain ischemia, which were closely related to the patho-
genesis of brain injury and might critically determine 
the outcome and prognosis of brain ischemia [23–25]. 
It has been reported that LRIP treatment could decrease 
expression of inflammation mediators interleukin-1beta 
(IL-1β) and IL-6, while they are important for neuropro-
tection under LRIP condition [26]. In our experimental 
model, LRIP exhibits significant neuroprotection in brain 
ischemia rats, and the molecular mechanism should 
involve the modulation of HIF-1α.
HIF-1α is a critical regulator contributing to adaptive 
responses to hypoxia, and HIF-1α can regulate cellular 
transductions under hypoxic milieu and inflammatory 
conditions [27–29]. During cerebral ischemic injury, 
HIF-1α was upregulated which may be involved in inflam-
mation processes. Evidence showed that HIF-1α admin-
istration could regulate glycolytic capacity in myeloid 
cell to reduce myeloid infiltration to affect inflamma-
tory progression. Suppression of HIF-1α in macrophages 
and neutrophils may result in inhibition of inflammatory 
reaction [30]. Whereas, HIF-1α deficiency may reduce 
the expression of tumor necrosis factor- alpha (TNF-α), 
interleukin-1 beta (IL-1β), cyclooxygenase-2, and induc-
ible nitric oxide synthase levels in the ileal mucosa after 
trauma hemorrhagic shock (T/HS) [31], which might 
eventually contribute to structural and functional recov-
ery. Literature showed that HIF-1α could regulate the 
expression of inducible nitric oxide synthase (iNOS) to 
affect inflammatory response during the ischemic phase of 
shock [32]. In addition, HIF-1α could significantly upregu-
late TNF-α to progress inflammatory response in the sep-
sis process formation and alveolar macrophages activated 
by lipopolysaccharide (LPS) [33]. By increasing the oxy-
gen-dependent expression of T cell immunoglobulin and 
mucin domain protein (TIM)-3 in glial cells, HIF-1α could 
indirectly influence the infiltration of neutrophils into the 
hypoxic penumbra, which was regarded as a main cause of 
ischemic brain damage [34]. Therefore, HIF-1α is a crucial 
molecule in inflammatory response progress.
In our study, overexpression of HIF-1α was induced 
by IRI, while it was markedly attenuated in LRIP group 
during early cerebral ischemia. Therefore, the inhibi-
tion of HIF-1α may be critical mechanism for neuropro-
tection induced by LRIP. The present finding revealed 
LRIP exhibiting a neuroprotective role was related with 
the inhibition of HIF-1α, a critical inflammation media-
tor during brain ischemia. Additionally, inhibition of 
HIF-1α in LRIP may have other effects. As Liu BN [35] 
and Pichiule P [36] reported, HIF-1α could inhibit apop-
tosis pathway and improve angiogenesis in infarcted area 
via regulating vascular endothelial growth factor (VEGF), 
Fig. 5 The mRNA expression of HIF-1α and the number of HIF-1α positive cells after reperfusion. a The expression of HIF-1α mRNA. The level of 
HIF-1α in I/R group was much higher than in sham group at 1 day post operation (#p < 0.05). But after LRIP administration, the level of HIF-1α was 
much lower than I/R group (*p < 0.05). At 3 days and 7 days, LRIP group still had a lower mRNA level of HIF-1α than I/R group, but the difference was 
not statistical significance. b The change of HIF-1α protein at 3 days. The upper one shows the western blot of β-action and HIF-1α. The below one is 
the quantitative analysis. LRIP suppressed the protein level of HIF-1α (#p < 0.05), which was upregulated by cerebral ischemia injury (*p < 0.05)
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cleaving caspase-9 and erythropoietin (Epo). In our 
study, the expression of HIF-1α was markedly decreased 
in LRIP administration rats, which was associated with 
the improvement of neurological function, reduction of 
infarct size and brain edema. Therefore, we deduced that 
LRIP in MCAO rat model should be an effective method 
for the treatment of brain ischemia and the molecular 
events were possibly associated with the downregulation 
of HIF-1α expression.
Conclusions
LRIP can significantly reduce cerebral damage caused by 
IRI, and the mechanisms are related to inhibiting the over-
expression of HIF-1α to suppress inflammatory response. 
These available findings not only confirm the neuropro-
tective effect of LRIP, but also provide new information 
to understand the role of HIF-1α as a novel target for the 
treatment of brain ischemia in future clinic practice.
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